Table 1

Baseline characteristics for all acute myocardial infarction patients with and without schizophrenia between 2000 and 2018 in Sweden

Schizophrenia
(n=1008)
Without schizophrenia
(n=285 325)
Total
(n=286 333)
Missing n (%)P value
Age median (1st–3rd quartiles)64 (56–71)73 (63–81)71.3 (12.3)0<0.001
Male sex, n (%)652 (64.7)183 568 (64.0)183 220 (64.0)00.646
Occupational status, n (%)58 897 (20.6)<0.001
 Working46 (4.6)48 611 (17.0)48 657 (17.0)
 Sick leave102 (10.1)4675 (1.6)4777 (1.7)
 Unemployed16 (1.6)2988 (1.1)2004 (1.1)
 Retired574 (56.9)162 199 (56.9)162 773 (56.9)
 Student/other12 (1.2)679 (0.2)691 (0.2)
Smoking status, n (%)25 047 (8.8)<0.001
 Never224 (22.2)116 923 (41.0)117 147 (40.9)
 Ex-smoker (>1 month)184 (18.3)86 514 (30.3)86.7 (30.3)
 Smoker489 (48.5)56 953 (20.0)57 441 (20.1)
Diabetes, n (%)394 (39.1)68 429 (24.0)68 823 (24.0)0<0.001
Hypertension454 (45.0)158 726 (55.6)159 180 (55.6)0<0.001
Hyperlipidaemia305 (30.3)93 157 (32.7)93 462 (32.6)3786 (1.3)0.062
Previous myocardial infarction, n (%)250 (24.8)76 102 (26.7)76 352 (26.7)00.18
Previous PCI, n (%)79 (7.8)30 523 (10.7)30 602 (10.1)00.003
Previous CABG, n (%)29 (2.9)20 823 (7.3)20 852 (7.3)0<0.001
Previous stroke, n %126 (12.5)34 392 (12.1)34 518 (12.1)00.664
Heart failure, n (%)200 (19.8)43 624 (15.3)43 824 (15.3)0<0.001
Chronic kidney disease, n (%)201 901 (70.5)0.031
 Stage 1 (GFR>90 mL/min/1.73 m2)212 (21.0)67 610 (23.7)67 822 (23.7)
 Stage 2 (GFR of 60–89 mL/min/1.73 m2)43 (4.3)14 859 (5.2)14 902 (5.2)
 Stage 3 (GFR of 30–59 mL/min/1.73 m2)10 (1.0)1698 (0.6)1708 (0.6)
COPD, n (%)132 (13.1)20 008 (7.0)20 140 (7.0)0<0.001
Previous bleeding, n (%)74 (7.3)16 765 (5.9)16 839 (5.9)00.048
Peripheral artery disease, n (%)42 (4.2)16 799 (5.9)16 841 (5.9)00.02
  • CABG, coronary artery bypass graft; COPD, chronic obstructive pulmonary disease; GFR, glomerular filtration rate; PCI, percutaneous coronary intervention.